southwestern
intern
medicin
confer
pneumonia
adult
due
mycoplasma
chlamydia
virus
jame
p
lubi
md
abstract
pneumonia
adult
due
mycoplasma
chlamydia
virus
common
clinic
problem
microorgan
contribut
etiolog
case
pneumonia
sole
pathogen
hospit
case
import
trend
develop
field
includ
emerg
chlamydia
psittaci
strain
twar
passag
human
human
caus
mycoplasmalik
ill
rel
resist
erythromycin
recognit
respiratori
syncyti
viru
pathogen
nurs
home
outbreak
immunosuppress
adult
continu
high
lethal
fulli
develop
influenza
pneumonia
efficaci
acyclovir
adenin
arabinosid
limit
complic
varicellazost
viru
infect
increas
frequenc
pneumonia
caus
cytomegaloviru
sever
disord
highli
immunosuppress
patient
develop
rapid
diagnosi
therapi
respiratori
syncyti
viru
infect
aerosol
antivir
drug
children
may
pave
way
compar
advanc
difficult
pneumonia
adult
patient
key
populationbas
studi
incid
ofpneumonia
perform
infrequ
one
studi
interv
decemb
novemb
foy
col
leagu
determin
incid
pneumonia
prepaid
medic
health
insur
plan
compris
member
seattl
washington
found
total
pneumonia
rate
vari
yearli
rang
populationyear
case
seen
physician
care
group
hospit
total
number
case
manag
outpati
adult
case
pneumonia
associ
cultur
andor
serolog
evid
mycoplasma
andor
viral
infect
total
rate
case
pneumonia
increas
influenza
epidem
year
highest
rate
gener
found
winter
quarter
follow
rate
occur
spring
quarter
figur
major
viral
mycoplasma
agent
contribut
etiolog
pneumonia
studi
influenza
viru
mycoplasma
pneumonia
follow
smaller
number
case
due
adenovirus
influenza
b
viru
respiratori
syncyti
viru
rsv
parainfluenza
virus
parainfluenza
viru
infect
caus
type
attempt
made
ascertain
exact
contribut
specif
agent
involv
antigen
overlap
complement
fixat
test
recogn
major
pneumonia
associ
influenza
relat
bacteri
suprainfect
rate
pneumonia
highest
young
children
follow
peak
pneumonia
due
pneumonia
age
group
pneumonia
due
influenza
viru
increas
incid
age
year
interest
find
sometim
pneumonia
associ
laboratori
evid
infect
one
respiratori
nonbacteri
agent
sever
diseas
appear
differ
patient
singl
infect
multipl
infect
measur
durat
ill
hospit
rate
individu
report
howev
suggest
certain
individu
multipl
infect
sometim
lead
sever
cours
would
predict
infect
singl
agent
overal
rate
pneumonia
determin
studi
similar
observ
nation
health
survey
houston
texa
year
adult
hospit
pneumonia
increas
sharpli
influenza
epidem
chang
much
influenza
b
epidem
find
also
seen
seattl
studi
figur
although
hospit
pneumonia
increas
houston
influenza
b
epidem
increas
number
patient
hospit
complic
due
influenza
b
viru
infect
seen
dalla
texa
time
etiolog
communityacquir
pneumonia
adult
outpati
sweden
determin
use
rise
antibodi
titer
acut
convalesc
sera
determin
etiolog
investig
found
evid
mycoplasma
pneumonia
infect
streptococcu
pneumonia
hemophilu
luenza
type
band
nontyp
influenza
viru
chlamydia
psittaci
influenza
b
viru
parainfluenza
viru
respiratori
syncyti
viru
adenoviru
multipl
infect
occur
sever
patient
serolog
evid
infect
particular
microorgan
etiolog
agent
communityacquir
pneumonia
adult
patient
hospit
diseas
examin
tabl
six
recent
studi
select
analysi
worldwid
authorship
attempt
made
estim
contribut
made
bacteri
nonbacteri
bacteri
etiolog
contribut
significantli
problem
communityacquir
pneumonia
adult
hospit
patient
frequent
microorgan
streptococcu
pneumonia
follow
staphylococcu
aureu
haemophilu
luenza
legionella
pneumophila
gramneg
bacteria
role
anaerob
bacteria
etiolog
pneumonia
studi
systemat
five
seri
nottingham
england
studi
accentu
role
l
pneumophila
etiolog
pneumonia
show
propens
microorgan
associ
specif
geograph
site
major
nonbacteri
agent
implic
studi
includ
pneumonia
influenza
b
virus
adenovirus
rsv
parainfluenza
virus
varicella
c
psittaci
latter
agent
could
seen
singl
pathogen
influenza
b
virus
adenovirus
rsv
parainfluenza
virus
varicella
viru
also
associ
bacteri
pneumonia
nonbacteri
agent
contribut
etiolog
case
indic
approxim
incid
nonbacteri
pneumonia
without
bacteri
suprainfect
ascertain
five
seri
rang
case
associ
influenza
b
virus
rubeola
viru
varicella
viru
bacteri
suprainfect
well
establish
recent
bacteri
suprainfect
shown
occur
adult
evid
infect
adenovirus
rsv
frequenc
bacteri
suprainfect
associ
pneumonia
infect
difficult
ascertain
consid
concept
primari
atyp
pneumonia
set
forth
articl
hobart
reimann
major
bacteriacaus
pneumonia
known
time
except
l
pneumophila
clinic
entiti
psittacosi
elucid
influenza
viru
grown
ferret
laidlaw
andrew
smith
reimann
describ
eight
case
call
atyp
pneumonia
thought
due
filter
viru
descript
case
allow
view
untreat
primari
atyp
pneumonia
seem
probabl
pneumonia
etiolog
agent
case
ill
often
began
inth
american
journal
medic
scienc
sidious
fever
headach
pharyng
descent
diseas
respiratori
tract
larynx
becam
involv
hoars
present
final
laryngotracheobronch
pneumonia
occur
troublesom
cough
develop
patient
could
allevi
slightli
product
patient
pulsetemperatur
dissoci
occur
cours
diseas
often
last
sever
week
patient
becam
dyspneic
cyanot
two
patient
becam
deliri
central
nervou
system
dysfunct
cours
infect
physic
examin
patient
flush
evid
pharyng
physic
examin
chest
usual
reveal
scatter
rale
without
strike
evid
consolid
one
patient
larg
pleural
effus
present
white
blood
count
modestli
elev
chest
radiograph
reveal
mottl
diffus
area
infiltr
attempt
isol
pathogen
bacteria
influenza
viru
unsuccess
establish
etiolog
syndrom
reimann
consid
diagnos
typhoid
psittacosi
epidem
influenza
histori
none
case
consist
influenza
viru
could
recov
summar
reimann
word
infect
occur
adult
began
mild
infect
respiratori
tract
follow
sever
diffus
atyp
pneumonia
two
case
symptom
enceph
dyspnea
cyanosi
hoars
cough
without
sputum
drowsi
profus
sweat
chief
characterist
diseas
last
sever
week
finland
found
elev
cold
agglutinin
titer
case
atyp
pneumonia
eaton
later
isol
agent
embryon
egg
chanock
colleagu
abl
grow
defin
media
demonstr
mycoplasma
entiti
primari
atyp
pneumonia
becam
well
known
later
defin
pneumonia
clear
penicillin
sulfonamid
nonbacteri
pneumonia
pneumonia
sputum
mucoid
sputum
without
predomin
organ
gram
stain
recogn
today
clinic
entiti
primari
atyp
pneumonia
multipl
etiolog
particularli
pneumonia
also
c
psittaci
twar
strain
ofcpsittaci
chlamydia
trachomati
qfever
virus
adenovirus
rsv
influenza
virus
influenza
virus
l
pneumophila
infect
often
consid
differenti
diagnosi
ls
earli
bacteri
pneumonia
also
consid
patient
first
seen
retrospect
person
diagnosi
often
exclud
seri
case
focu
specif
nonbacteri
natur
problem
pertin
geograph
area
acut
histoplasmosi
coccidioidomycosi
may
present
like
primari
atyp
pneumonia
major
attempt
identifi
etiolog
agent
clinic
ground
made
exact
diagnosi
usual
depend
laboratori
determin
offend
agent
one
studi
patient
age
viral
pneumonia
mycoplasma
pneumonia
bacterem
meumococc
pneumonia
compar
best
discrimin
variabl
creactiv
protein
determin
presenc
absenc
predispos
diseas
previou
antibiot
treatment
erythrocyt
sediment
rate
presenc
lymphocytosi
band
neutrophil
count
sign
upper
respiratori
tract
infect
presenc
absenc
auscultatori
abnorm
also
aid
significantli
discrimin
determin
favor
bacterem
pneumococc
pneumonia
includ
predispos
diseas
short
durat
ill
hospit
alcohol
absenc
sign
upper
respiratori
tract
infect
high
creactiv
protein
determin
erythrocyt
sediment
rate
prior
antibiot
treatment
total
leukocyt
count
exceed
rel
lymphocyt
count
less
rel
band
neutrophil
count
greater
abnorm
auscultatori
find
presenc
lobar
consolid
chest
radiograph
differenti
viral
mycoplasma
pneumonia
could
made
easili
howev
symptom
mycoplasma
pneumonia
hospit
last
longer
time
patient
like
receiv
antibiot
treatment
interv
hospit
patient
mycoplasma
pneumonia
like
lobar
consolid
chest
radiograph
viral
pneumonia
studi
distinct
could
made
mycoplasma
pneumonia
bacterem
pneumococc
pneumonia
basi
roentgenograph
find
alon
anoth
studi
compar
communityacquir
pneumonia
mycoplasma
pneumonia
tend
occur
earlier
age
legionnair
diseas
pneumococc
pneumonia
psittacosisl
homogen
shadow
chest
radiograph
common
legionnair
diseas
pneumococc
pneumonia
mycoplasma
pneumonia
pleural
effus
uncommon
group
occur
commonli
bacterem
pneumococc
pneumonia
multilob
diseas
present
hilar
lymphadenopathi
occur
mycoplasma
pneumonia
roentgenograph
resolut
fastest
mycoplasma
pneumonia
intermedi
psittacosi
nonbacterem
pneumococc
pneumonia
slowest
legionnair
diseas
bacterem
pneumococc
pneumonia
deterior
chest
radiograph
hospit
admiss
character
legionnair
diseas
bacterem
pneumococc
pneumonia
differenti
diagnosi
primari
atyp
pneumonia
clinic
level
includ
pneumonia
due
pneumonia
chlamydi
speci
q
fever
adenovirus
rsv
influenza
virus
parainfluenza
virus
well
l
pneumophila
infect
earli
bacteri
pneumonia
therapi
includ
antibiot
major
american
journal
medic
scienc
lubi
microorgan
suscept
chlamydi
speci
suscept
tetracyclin
erythromycin
tetracyclin
effect
rickettsia
l
pneumophila
infect
pneumococc
isol
resist
tetracyclin
reason
antibiot
choic
erythromycin
equival
dose
mglkg
erythromycin
base
per
day
day
legionnair
diseas
diagnos
higher
dose
erythromycin
may
necessari
chlamydi
rickettsi
etiolog
recogn
tetracyclin
dose
gmiday
given
occasion
patient
proven
pneumonia
treat
erythromycin
fail
respond
therapi
subsequ
respond
cours
tetracyclin
therapyl
convers
patient
pneumonia
infect
respond
erythromycin
suboptim
respons
tetracyclin
therapi
virus
may
caus
primari
atyp
pneumonia
howev
antibiot
treatment
instanc
useless
prevent
suprainfect
may
actual
chang
natur
bacteri
speci
suprainfect
patient
antibiot
therapi
seem
reason
syndrom
howev
usual
imposs
differenti
clinic
mycoplasma
pneumonia
entiti
adenoviru
pneumonia
adult
advanc
rapid
laboratori
diagnosi
may
abl
futur
influenc
treatment
option
techniqu
still
develop
expens
wide
avail
mycoplasma
smallest
freeliv
microorgan
cellwal
defici
relationship
cellwal
defici
bacteria
confus
pneumonia
attach
mucos
epithelium
respiratori
tract
specif
protein
enabl
microorgan
adher
neuramin
acid
residu
respiratori
epitheli
cell
mycoplasma
attach
damag
host
upon
adher
mycoplasma
abl
gener
hydrogen
peroxid
superoxid
anion
result
injuri
epitheli
cell
infect
occur
commonli
children
younger
year
age
although
diseas
rare
time
life
mycoplasma
may
induc
diseas
primarili
immunopatholog
mechan
lb
experiment
anim
prime
prior
mycoplasma
exposur
inflammatori
chang
occur
long
interv
reinfect
inflammatori
chang
occur
briskli
extrapulmon
manifest
coplasma
infect
never
explain
complet
report
demonstr
pneumonia
site
cerebrospin
fluid
blood
altern
immunopatholog
reaction
may
primari
mechan
involv
patholog
diseas
man
character
tracheobronchi
bronchiolar
septal
lymphoplasmocyt
infiltr
lumin
exud
rich
polymorphonuclear
leukocyt
bronchiolar
alveolar
cell
metaplasia
occasion
diffus
alveolar
bronchiol
appear
major
site
attack
microorgan
colon
nasopharynx
transmiss
infect
occur
close
contact
especi
conduc
transmiss
pneumonia
situat
person
hous
close
quarter
militari
platoon
barrack
famili
unit
dwell
famili
high
attack
rate
case
continu
occur
cumul
attack
rate
mycoplasma
infect
famili
may
approach
figur
mycoplasma
carriag
affect
antibiot
therapi
therebi
allow
famili
epidem
continu
mycoplasma
diseas
occur
throughout
year
particularli
frequent
fall
winter
increas
number
case
occur
period
although
pneumonia
may
occur
soon
infect
diseas
usual
manifest
upper
respiratori
tract
infect
progress
descend
lung
pharyng
progress
laryng
follow
tracheobronch
final
pneumonia
hoars
dysphonia
may
present
middl
ear
involv
may
occur
bullou
myring
usual
heal
without
scar
occasion
otiti
may
lead
tympan
membran
perfor
sinu
involv
frequent
usual
asymptomat
cough
often
intract
usual
slightli
product
mucoid
sputum
contain
mainli
polymorphonuclear
leukocyt
predomin
bacteri
microorgan
gram
stain
pneumonia
develop
patient
elev
temperatur
occasion
temperaturepuls
dissoci
headach
irrit
flush
faci
myalgia
arthralgia
common
physic
examin
patient
febril
appear
flush
usual
physic
evid
pharyng
hemorrhag
bullou
myring
may
present
case
physic
find
chest
examin
usual
limit
scatter
rale
wheez
rhonchi
often
local
lung
base
evid
consolid
strike
although
pneumonia
infect
caus
lobar
pneumonia
white
count
usual
elev
shift
left
rare
exce
white
blood
cellsmm
neutrophil
band
count
usual
less
chest
radiograph
reveal
peribronchi
infiltr
accentu
interstiti
mark
adjac
lung
segment
patchi
alveolar
infiltr
usual
local
lower
lobe
especi
left
occasion
hilar
lymphadenopathi
one
lobe
may
involv
confluent
lobar
infiltr
may
present
patient
figur
less
commonli
diffus
interstiti
infiltr
rare
xray
pictur
indistinguish
adult
respiratori
distress
syndrom
without
therapi
diseas
cours
usual
last
approxim
week
may
extend
week
extrapulmon
manifest
mycoplasma
infect
often
clue
diagnosi
includ
bullou
myring
neurolog
disturb
suggest
enceph
asept
mening
rare
transvers
myeliti
arthriti
myopericard
hepat
dysfunct
splenomegali
skin
eruptionsu
stevensjohnson
syndrom
may
occur
japanes
worker
describ
typic
case
pityriasi
rosea
follow
mycoplasma
infect
cerebrospin
fluid
csf
may
abnorm
increas
number
cell
elev
protein
concentr
hemolyt
anemia
may
present
result
antibodi
direct
antigen
redcel
membran
almost
patient
recov
complet
mycoplasma
infect
cigarett
smoker
may
prolong
abnorm
diffus
individu
case
report
describ
pulmonari
fibrosi
bronchiol
obliteran
bronchiectasi
follow
pneumonia
glomerulonephr
continu
renal
dysfunct
also
report
diagnosi
establish
cultur
microorgan
demonstr
fourfold
rise
antibodi
complement
fixat
serolog
test
singl
high
complement
fixat
test
antibodi
titer
may
use
presumpt
evid
infect
cold
agglutinin
antibodi
titer
low
level
norispecif
high
valu
also
use
support
diagnosi
treatment
consist
administr
either
erythromycin
tetracyclin
outlin
therapi
primari
atyp
pneumonia
patient
usual
respond
rememb
report
inadequ
resolut
diseas
necess
switch
altern
drug
achiev
rapid
clinic
improv
antibiot
therapi
elimin
carrier
state
immun
rel
shortlast
document
episod
repeat
mycoplasma
infect
report
vaccin
pneumonia
given
present
prioriti
appear
hope
futur
develop
mycoplasma
pneumonia
man
well
day
admiss
hospit
time
develop
fever
sore
throat
nonproduct
cough
oral
temperatur
reach
c
pound
headach
develop
cough
persist
becam
product
mucoid
sputum
oral
penicillin
prescrib
allevi
symptom
physic
examin
admiss
hospit
reveal
young
man
confus
time
uncertain
recent
event
oral
temperatur
c
puls
rate
pharynx
describ
normal
chest
examin
reveal
harsh
breath
sound
bilater
inspiratori
rale
especi
right
anteriorli
inferiorli
egophoni
decreas
fremitu
rhonchi
present
right
left
hepatosplenomegali
present
laboratori
examin
reveal
white
blood
cell
polymorphonuclear
cell
lymphocyt
one
monocyt
one
eosinophil
serum
aspart
aminotransferas
normal
arteri
blood
gase
room
air
show
ph
lumbar
punctur
perform
show
white
blood
cell
mononuclear
cell
csf
glucos
mgdl
simultan
plasma
glucos
mgdl
patient
treat
initi
intraven
penicillin
presum
pneumococc
pneumonia
partial
treat
bacteri
mening
condit
deterior
final
place
erythromycin
therapi
advic
consult
mycoplasma
complement
fixat
test
titer
rose
less
comment
enceph
hepatosplenomegali
mild
hepat
dysfunct
extrapulmon
manifest
mycoplasma
diseas
typic
mycoplasma
pneumonia
long
durat
ill
admiss
hospit
prior
antibiot
administr
presenc
sore
throat
physic
examin
chest
characterist
sputum
psittacosi
first
describ
ritter
switzerland
diseas
lung
patient
contact
sick
psittacin
bird
later
pandem
psittacosi
occur
involv
psittacin
bird
export
south
america
clinic
manifest
describ
fulli
epidemiolog
establish
lead
control
measur
kept
psittacosi
better
inclus
term
ornithosi
low
level
occurr
occasion
migrant
bird
carri
c
psittaci
person
deal
may
develop
ornithosi
importantli
ornithosi
occup
hazard
farmer
manag
poultri
duck
clinic
patient
ornithosi
headach
fever
pulsetemperatur
dissoci
pneumonia
hepat
function
abnorm
hepatosplenomegali
intraalveolar
inflammatori
chang
predomin
ornithosi
interstiti
chang
secondari
less
promin
chest
radiograph
reflect
lobar
consolid
may
seen
lung
involv
minor
diseas
diagnost
confus
present
fever
undetermin
origin
granuloma
format
found
liver
bone
marrow
may
diagnost
clue
ornithosi
diagnos
serolog
test
chlamydi
common
group
antigen
either
complement
fixat
enzymelink
immunoabsorb
assay
eia
treatment
tetracyclin
day
chlamydia
trachomati
caus
afebril
pneumonialik
syndrom
young
infant
begin
age
month
character
afebril
state
failur
gain
weight
staccatolik
cough
examin
rale
expiratori
wheez
evid
hyperaer
lung
chest
radiograph
usual
reveal
diffus
interstiti
pneumonia
hyperaer
lung
field
laboratori
determin
show
modest
eosinophilia
hyperglobulinemia
upon
identif
infant
treat
oral
erythromycin
syrup
week
benefit
recent
c
trachomati
isol
lower
respiratori
tract
immunosuppress
patient
pneumonia
although
four
six
patient
report
one
test
show
serolog
respons
microorgan
case
communityacquir
pneumonia
normal
adult
also
report
serolog
evid
infect
c
trachomati
fiftytwo
patient
studi
seven
found
definit
suggest
serolog
evid
infect
seven
rang
age
chest
radiograph
patient
analyz
infiltr
found
patchi
characterist
streaki
area
plate
atelectasi
particular
local
singl
lobe
three
patient
radiograph
evid
ofmultilobar
involv
studi
need
done
corrobor
report
determin
frequenc
lung
involv
occur
finland
epidem
mild
pneumonia
relat
newli
describ
strain
c
psittaci
capabl
passag
human
human
epidem
occur
adolesc
young
adult
point
preval
pneumonia
student
time
xray
survey
contribut
particular
strain
c
psittaci
design
twar
strain
first
two
isol
examin
best
studi
univers
washington
infect
student
usual
present
mild
pneumonia
simul
mycoplasma
infect
often
associ
pharyng
laryng
studi
twar
strain
c
psittaci
caus
pneumonia
student
popul
twar
strain
c
psittaci
isol
student
serial
sera
show
convers
common
chlamydi
group
antigen
complement
fixat
test
microimmunofluoresc
test
reveal
specif
reaction
twar
strain
c
psittaci
microorgan
isol
student
form
typic
inclus
bodi
tissu
cultur
stain
iodin
consid
typic
c
psittaci
cluster
case
epidemiolog
suggest
humantohuman
transmiss
birdtohuman
transmiss
could
demonstr
case
treatment
tetracyclin
shorten
cours
occasion
patient
respond
gm
erythromycin
given
day
new
strain
c
psittaci
isol
patient
serolog
reaction
specif
antigen
demonstr
evid
link
c
trachomati
lung
diseas
either
isol
alon
serolog
test
studi
similar
one
seattl
need
perform
link
c
trachomati
lung
diseas
clear
howev
new
strain
c
psittaci
exist
caus
diseas
commonli
diseas
due
microorgan
diagnos
complement
fixat
eia
test
use
chlamydi
group
antigen
special
laboratori
isol
organ
also
perform
microimmunofluoresc
test
major
new
develop
evalu
patient
primari
typic
pneumonia
emerg
c
psittaci
strain
capabl
passag
human
human
may
desir
respons
erythromycin
treatment
adenovirus
ubiquit
nonenvelop
dna
virus
colon
human
nasopharynx
transmit
person
close
contact
type
recogn
capac
produc
epidem
militari
recruit
popul
transmiss
group
virus
depend
upon
close
human
contact
diseas
often
produc
home
militari
recruit
barrack
pathogenet
lung
infect
usual
follow
pharyng
movement
diseas
process
respiratori
tract
although
case
pneumonia
sever
case
come
autopsi
show
tracheobronchi
mucosa
denud
normal
epitheli
structur
basal
layer
squamou
metaplasia
occur
along
interstiti
space
thicken
due
presenc
chronic
inflammatori
cell
alveolar
edema
mononuclear
cell
infiltr
present
pneumonia
infect
infiltr
often
peribronchi
peribronchiolar
distribut
nuclear
inclus
bodi
nuclei
smudg
appear
may
found
epitheli
cell
clinic
diseas
often
begin
pharyng
associ
fever
anterior
cervic
lymphadenopathi
without
conjunct
involv
tracheobronchi
tree
final
parenchyma
lung
pneumonia
common
infant
young
children
militari
recruit
militari
recruit
popul
mycoplasma
adenoviru
pneumonia
found
indistinguish
clinic
except
increas
lubi
frequenc
exud
pharyng
adenoviru
infect
physic
examin
reveal
pharyng
rhiniti
scatter
rale
rhonchi
evid
consolid
infrequ
occasion
lobar
consolid
occur
pleural
effus
figur
viru
rare
isol
pleural
fluid
fatal
case
adenoviru
pneumonia
occur
infant
immunosuppress
patient
rare
normal
person
case
pneumonia
progress
develop
diffus
bilater
alveolar
infiltr
hypoxemia
requir
ventil
assist
correct
infiltr
progress
leukopenia
ensu
mark
lymphocytopenia
rhabdomyolysi
occur
along
evid
dissemin
intravascular
coagul
renal
failur
termin
patient
becom
obtund
bacteri
suprainfect
associ
adenoviru
pneumonia
suprainfect
speci
bacteria
includ
pneumonia
group
cocci
h
influenza
aureu
group
neisseria
meningitidi
militari
recruit
increas
frequenc
group
meningococc
suprainfect
observ
microorgan
commonli
colon
nasopharynx
popul
administr
antibiot
cours
adenoviru
pneumonia
prevent
bacteri
suprainfect
although
person
recov
unev
adenoviru
pneumonia
occasion
patient
residu
abnorm
restrict
lung
diseas
bronchiectasi
bronchiol
obliteran
extrapulmon
mani
festat
adenoviru
infect
includ
pharyng
conjunct
pericard
arthriti
skin
rash
hepat
dysfunct
rey
syndrom
describ
cours
adenoviru
pneumonia
occurr
one
manifest
cours
pneumonia
lead
physician
order
appropri
diagnost
test
make
specif
etiolog
diagnosi
viru
isol
nasopharynx
sputum
endotrach
secret
antigen
detect
immunofluoresc
test
eia
dna
hybrid
within
epitheli
cell
deriv
respiratori
tract
latter
test
specif
present
time
less
sensit
viral
cultur
specif
therapi
infect
oral
live
attenu
vaccin
avail
type
adenovirus
use
militari
prevent
epidem
diseas
fatal
adenoviru
pneumonia
man
unremark
past
histori
except
hypertens
control
medic
two
week
admiss
develop
nonproduct
hack
cough
began
dyspnea
increas
time
admiss
physic
examin
appear
moder
respiratori
distress
oral
temperatur
c
puls
rate
blood
pressur
respiratori
rate
oropharynx
describ
normal
scatter
rhonchi
rale
heard
diffus
lung
summat
gallop
heard
cardiac
apex
laboratori
examin
reveal
white
blood
count
polymorphonuclear
cell
band
form
lymphocyt
monocyt
arteri
blood
gase
room
air
show
ph
pco
po
ekg
show
left
ventricular
hypertrophi
chest
radiograph
reveal
enlarg
cardiac
silhouett
patchi
alveolar
infiltr
ofth
entir
right
lung
left
lower
lobe
patient
start
erythromycin
mg
everi
hour
intraven
continu
spike
temperatur
c
cefamandol
tobramycin
ad
antibiot
therapi
two
day
admiss
creatin
phosphokinas
valu
rose
next
day
creatinin
rose
mgdl
heart
enlarg
radiograph
pulmonari
infiltr
continu
increas
mental
statu
gradual
deterior
transfer
intens
care
unit
white
blood
count
lymphocyt
develop
evid
dissemin
intravascular
coagul
die
eighth
hospit
day
respiratori
insuffici
postmortem
examin
reveal
chang
viral
pneumonia
epitheli
cell
show
intranuclear
inclus
appear
smudg
nuclei
enlarg
heart
due
idiopath
myocardi
diseas
minim
patholog
evid
hypertens
find
dissemin
intravascular
coagul
electron
microscopi
oflung
section
reveal
adenoviru
adenoviru
complement
fixat
test
titer
rose
less
comment
patient
febril
period
admiss
pulmonari
infiltr
progress
antibiot
therapi
develop
leukopenia
lymphocytopenia
rhabdomyolysi
dissemin
intravascular
coagul
acut
renal
failur
ill
occur
set
idiopath
myocardi
diseas
possibl
mild
chronic
left
ventricular
failur
might
predispos
sever
adenovir
pneumonia
similar
manner
cardiac
failur
augment
influenza
pneumonia
pneumonia
due
respiratori
syncyti
viru
respiratori
syncyti
viru
predomin
respiratori
tract
viral
pathogen
infanc
young
childhood
infect
adult
usual
result
symptom
mild
upper
respiratori
tract
ill
common
cold
recogn
immunosuppress
patient
elderli
person
develop
pneumonia
rsv
sever
complic
bacteri
suprainfect
furthermor
sinc
immunosuppress
elderli
person
may
aggreg
hospit
nurs
home
institut
often
site
acquisit
infect
epidem
pneumonia
febril
respiratori
ill
took
place
lo
angel
februarymarch
forti
resid
affect
pneumonia
eight
person
die
casefat
rate
outbreak
record
nosocomi
acquisit
ofrsv
difficult
prevent
hospit
personnel
becom
colon
may
mild
respiratori
tract
symptom
transfer
viru
occur
patient
personnel
patient
transmiss
directli
personnel
hand
fomit
becom
contamin
respiratori
secret
viru
spread
patient
direct
contact
sourc
patholog
pneumonia
due
rsv
similar
viral
pneumonia
howev
epitheli
cell
intracytoplasm
inclus
bodi
seen
xray
appear
pneumonia
diffus
interstiti
process
interstiti
patchi
alveolar
infiltr
lower
lobe
appear
indistinguish
adult
respiratori
distress
syndrom
pneumonia
due
rsv
immunosuppress
elderli
person
newli
describ
phenomenon
one
may
increas
import
also
import
rsv
infect
diagnos
earli
antigen
detect
techniqu
immunofluoresc
eia
effect
therapi
develop
recent
antigen
detect
test
rsv
equal
exceed
efficaci
viral
cultur
diagnosi
infect
respiratori
syncyti
viru
infect
infanc
treat
success
aerosol
ribavirin
therapi
indic
infant
children
lower
respiratori
tract
involv
rsv
except
ill
may
congenit
heart
diseas
bronchopulmonari
dysplasia
aerosol
deliveri
oxygen
tent
hood
mask
concentr
ribavirin
quit
high
upper
lower
respiratori
tract
exceed
minimum
inhibitori
concentr
necessari
inhibit
growth
viru
tissu
cultur
achiev
concentr
oral
administr
drug
unaccept
toxic
would
encount
toxic
would
includ
bone
marrow
depress
particularli
anemia
relat
matur
arrest
lesser
extent
hemolysi
latter
event
occur
ribavirin
triphosph
accumul
erythrocyt
halflif
greater
day
interfer
format
guanosin
triphosph
aerosol
ribavirin
therapi
expens
present
approv
food
drug
administr
therapi
complic
rsv
infect
infant
young
children
repres
first
exampl
effect
drug
treat
signific
lower
respiratori
tract
viral
infect
conceiv
technolog
could
appli
influenza
infect
influenza
rubeola
cover
detail
recogn
rna
virus
caus
lower
respiratori
tract
involv
adult
virus
includ
parainfluenza
virus
respiratori
enterovirus
coxsacki
b
virus
coxsacki
viru
rhinovirus
coronavirus
magnitud
problem
howev
appear
limit
document
instanc
sever
lower
respiratori
tract
infect
due
parainfluenza
ii
iii
virus
occur
howev
present
accept
therapi
latter
infect
although
aerosol
ribavirin
use
success
control
persist
parainfluenza
viru
infect
lower
respiratori
tract
immunodefici
children
influenza
viru
caus
pandem
epidem
occur
everi
everi
year
influenza
virus
possess
common
group
complement
fixat
test
antigen
nucleoprotein
antigen
influenza
virus
differ
antigen
charact
hemagglutinin
neuraminidas
strain
influenza
circul
world
asian
influenza
strain
becam
predomin
strain
circul
hong
kong
influenza
appear
strain
viru
continu
transmit
strain
began
circul
continu
influenza
b
strain
common
complement
fixat
test
antigen
differ
influenza
viru
hemagglutinin
neuraminidas
influenza
b
viru
less
prone
chang
pandem
diseas
due
viru
occur
interepidem
interv
longer
influenza
name
everi
year
seriou
morbid
due
influenza
viru
occur
host
factor
age
underli
diseas
immunosuppress
immun
wane
time
influenza
virus
constantli
chang
antigen
charact
pandem
year
hemagglutinin
neuraminidas
chang
concomitantli
american
journal
medic
scienc
lubi
tendenc
seriou
diseas
occur
one
surfac
protein
chang
well
illustr
pandem
influenza
virus
may
certain
occas
virul
epidem
pneumonia
rate
person
age
year
approxim
influenza
fact
cite
indic
virul
strike
pneumotrop
viru
led
million
death
occur
throughout
world
pandem
influenza
b
virus
like
caus
diseas
younger
person
occasion
epidem
occur
excess
mortal
pathogenet
influenza
viru
attach
cell
respiratori
epithelium
enter
process
term
receptormedi
endocytosi
virion
uncoat
endosom
fusion
membran
structur
process
requir
acid
ph
particl
undergo
cytoplasm
nuclear
stage
replic
virion
rna
cap
polymethyl
nucleu
rna
messag
recogn
cell
translat
ribosom
process
replic
viru
rapidli
destroy
respiratori
tract
epitheli
structur
order
compromis
natur
defens
mechan
lung
mucou
product
ciliari
activ
case
sever
pneumonia
epithelium
trachea
bronchi
destroy
basal
layer
metaplasia
occur
leav
respiratori
tract
coat
layer
squamou
cell
involv
bronchiolar
structur
intens
peribronchiolar
inflammatori
process
uncompl
influenza
small
airway
commonli
affect
produc
diffus
dysfunct
structur
mild
hypoxemia
compens
respiratori
alkalosi
sever
influenza
pneumonia
alveolar
cell
destruct
disrupt
alveolarcapillari
membran
result
hemorrhag
alveoli
along
edema
mononuclear
cell
infiltr
presenc
ofhyalin
membran
thicken
interstitium
occur
chronic
inflammatori
cell
infiltr
process
fulmin
occur
coincid
onset
ill
protract
lead
occurr
progress
infiltr
day
adult
respiratori
distress
syndromelik
pictur
produc
influenza
pneumonia
high
casefat
rate
may
approxim
influenza
pneumonia
sever
howev
case
interstiti
bronchopneumon
process
appar
diseas
simul
pneumonia
except
influenza
leukocyt
count
tend
normal
decreas
influenza
pneumonia
coexist
bacteri
suprainfect
bacteri
suprainfect
occur
alon
offend
bacteri
pathogen
may
vari
pandem
h
luenza
evid
major
pathogen
pandem
group
streptococcu
consid
major
pathogen
recent
pneumonia
common
offend
agent
follow
aureu
andh
luenza
occasion
gramneg
bacteria
may
involv
influenza
b
viru
caus
similar
spectrum
pulmonari
diseas
number
patient
involv
fewer
hospit
rate
lower
respiratori
tract
diseas
nearli
alway
increas
influenza
epidem
rate
tend
increas
influenza
b
epidem
although
total
hospit
may
increas
period
like
influenza
viru
influenza
b
viru
caus
varieti
diseas
process
outsid
lung
includ
myopericard
rhabdomyolysi
dissemin
intravascular
coagul
nervou
system
disturb
enceph
rey
syndrom
landryguillanbarr
syndrom
stevensjohnson
syndrom
other
clinic
patient
influenza
viru
pneumonia
sudden
onset
ever
prostrat
myalgia
follow
shortli
dyspnea
bloodting
sputum
may
produc
dyspnea
progress
hospit
ventilatori
support
requir
ill
also
assum
protract
cours
lead
progress
interstiti
alveolar
infiltr
week
figur
patient
simpli
viral
pneumonia
pulmonari
dysfunct
need
ventil
assist
complic
bacteri
suprainfect
may
coexist
viral
pneumonia
commonli
present
afebril
interv
patient
appear
recov
primari
infect
morbid
mortal
greatest
elderli
person
chronic
diseas
state
chronic
obstruct
pulmonari
diseas
chronic
congest
heart
failur
diabet
mellitu
immunosuppress
patient
morbid
due
influenza
b
virus
limit
group
howev
women
third
trimest
pregnanc
also
may
increas
rate
develop
influenza
pneumonia
death
due
diseas
process
renal
transplant
recipi
contract
influenza
ill
often
prolong
develop
viral
pneumonia
bacteri
suprainfect
myopericard
may
loss
renal
allograft
due
combin
diseas
process
influenza
b
viru
infect
diagnos
serial
titer
rise
suitabl
serolog
test
complement
fixat
hemagglutin
inhibit
test
singl
complement
fixat
test
titer
shown
correl
highli
recent
influenza
b
infect
viru
grown
nasopharynx
endotrach
secret
inocul
specimen
rhesu
monkey
kidney
madindarbi
canin
kidney
tissu
cultur
embryon
egg
sometim
need
use
figur
influenza
pneumonia
radiograph
lett
show
combin
influenza
pneumonia
lett
lower
lobe
consolid
indic
bacteri
supra
infect
radiograph
right
show
diffus
alveolar
infiltr
cours
serolog
document
influenza
infect
bacteri
cultur
endotrach
secret
consist
show
growth
optim
recoveri
viru
viru
may
abl
identifi
within
hour
use
immunofluoresc
direct
detect
antigen
immunofluoresc
eia
appli
appropri
secret
test
yet
sensit
viral
cultur
amantadin
rimantadin
two
compound
prophylact
therapeut
efficaci
influenza
influenza
b
viru
act
prevent
uncoat
influenza
viru
perhap
prevent
develop
acid
ph
envelop
virion
fuse
endosom
membran
dosag
given
mg
twice
day
amantadin
central
nervou
system
side
effect
dose
adjust
renal
failur
dose
rimantadin
adjust
renal
dysfunct
compound
metabol
bodi
studi
sponsor
nation
institut
health
underway
evalu
whether
rimantadin
use
effect
therapi
hospit
patient
influenza
would
includ
patient
influenza
viru
pneumonia
ribavirin
vitro
efficaci
influenza
b
virus
multipl
site
action
includ
interfer
format
guanosin
triphosph
deoxyguanosin
triphosph
prevent
placement
polymethyl
cap
structur
influenza
viral
rna
messag
aerosol
ribavirin
high
concentr
drug
produc
within
respiratori
tract
serum
level
low
attempt
like
made
futur
treat
influenza
viru
pneumonia
aerosol
ribavirin
combin
ofribavirin
rimantadin
influenza
b
viru
pneumonia
may
abl
treat
aerosol
ribavirin
vaccin
exist
influenza
b
virus
standard
medic
care
necessit
yearli
immun
elderli
patient
underli
medic
condit
recent
emphasi
public
health
servic
medic
personnel
also
immun
yearli
sinc
expos
person
influenza
may
develop
ill
may
transmit
infect
sick
patient
within
hospit
nosocomi
influenza
pneumonia
alcohol
man
admit
hospit
januari
alcohol
liver
diseas
macrocyt
anemia
symptom
bladder
neck
obstruct
heavi
smoker
evid
chronic
obstruct
pulmonari
diseas
lwelv
day
admiss
hospit
develop
fever
c
await
urolog
procedur
felt
terribl
myalgia
develop
cough
mild
diarrhea
dyspnea
chest
examin
reveal
diffus
rale
rhonchi
chest
radiograph
show
new
interstiti
infiltr
promin
right
sputum
mucoid
diagnosi
pneumonia
made
diagth
american
journal
medic
scienc
lubi
nosi
congest
heart
failur
pulmonari
edema
consid
howev
heart
examin
reveal
gallop
sound
neck
vein
distend
place
ampicillin
becam
afebril
day
dyspnea
improv
low
flow
oxygen
face
mask
influenza
complement
fixat
test
titer
singl
convalesc
serum
specimen
comment
influenza
viru
pneumonia
occur
hospit
pneumonia
clear
symptomat
therapi
public
health
servic
recommend
widespread
immun
medic
personnel
attempt
prevent
nosocomi
acquisit
influenza
although
predict
made
rubeola
would
erad
countri
earli
achiev
dalla
texa
case
rubeola
occur
mark
resurg
case
rel
diseasefre
interv
larg
epidem
occur
dalla
caus
case
includ
three
death
consequ
ofthi
epidem
texa
adopt
law
requir
compulsori
immun
children
measl
mump
rubella
poliomyel
diphtheria
tetanu
present
rubeola
vaccin
least
effect
univers
immun
preschool
child
practic
particularli
lower
socioeconom
class
popul
group
furthermor
rubeola
viru
found
violat
concept
herd
immun
major
principl
erad
base
outbreak
occur
high
school
colleg
larg
percentag
popul
immun
inactiv
vaccin
avail
children
receiv
inactiv
vaccin
may
develop
atyp
measl
exposur
rubeola
viru
follow
attenu
live
strain
measl
viru
use
vaccin
high
sidereact
frequenc
necessit
concomit
administr
vglobulin
recogn
concurr
use
vglobulin
sometim
render
immun
ineffect
mani
children
immun
age
month
effect
immun
occur
vaccin
must
given
age
month
consequ
lack
univers
preschool
immun
difficulti
relat
vaccin
exist
two
popul
group
may
nonimmun
respect
rubeola
ie
preschool
children
adolesc
young
adult
year
ago
rubeola
epidem
common
militari
recruit
follow
occurr
outbreak
recruit
routin
undergo
serolog
test
antibodi
rubeola
viru
detect
either
hemagglutin
inhibit
indirect
immunofluoresc
test
live
attenu
vaccin
given
practic
essenti
stop
occurr
outbreak
militari
person
receiv
inactiv
vaccin
develop
atyp
measl
first
case
new
syndrom
misdiagnos
rocki
mountain
spot
fever
confus
diseas
rash
began
extrem
spread
inward
involv
trunk
rash
could
maculopapular
vesicular
petechi
atyp
measl
pulmonari
involv
consist
nodular
infiltr
lobar
consolid
occurr
pleural
effus
hilar
lymphadenopathi
may
also
present
patient
anamnest
respons
antibodi
product
infect
mild
eosinophilia
may
also
present
viru
recov
nasopharynx
young
adult
typic
measl
approxim
develop
clinic
evid
pneumonia
radiograph
evid
pneumonia
howev
may
seen
patient
pneumonia
usual
character
diffus
bilater
interstiti
fine
reticulonodular
infiltr
particularli
affect
lower
lobe
bacteri
suprainfect
occur
mani
case
recogn
viral
pneumonia
type
bacteria
caus
infect
may
determin
circumst
diseas
occur
militari
recruit
popul
recogn
pathogen
includ
h
influenza
pneumonia
group
streptococci
group
meningococci
aureu
bacteri
suprainfect
gener
occur
fifth
tenth
day
rash
herald
clinic
worsen
new
differ
lung
infiltr
chang
sputum
characterist
white
blood
count
antibiot
treatment
viral
pneumonia
prevent
bacteri
suprainfect
immunodefici
children
measl
pneumonia
occur
without
rash
patholog
call
giantcel
pneumonia
recogn
children
lack
cellmedi
immun
depress
delay
antibodi
product
intact
cellmedi
immun
essenti
rash
product
fatal
rubeola
pneumonia
entir
tracheobronchi
tree
may
denud
cell
basal
layer
squamou
metaplasia
cell
occur
widen
interstiti
space
edema
inflammatori
cell
alveoli
fill
edema
hyalin
membran
mononuclear
cell
addit
giant
cell
contain
multipl
nuclei
found
within
tracheobronchi
epithelium
extrapulmon
manifest
measl
occur
includ
otiti
media
sinus
enceph
common
presenc
hepat
dysfunct
young
adult
mostli
consist
mild
elev
serum
aspart
aminotransferas
lactic
dehydrogenas
present
specif
therapi
public
health
author
think
reimmun
measl
mump
rubella
vaccin
given
child
enter
high
school
medic
personnel
sure
rubeola
immun
statu
assess
determin
specif
antibodi
varicellazost
viru
produc
pneumonia
cours
varicella
dissemin
herp
zoster
sever
diseas
lead
mortal
varicella
childhood
usual
associ
viral
pneumonia
bacteri
suprainfect
occur
necessit
appropri
antibiot
treatment
immunosuppress
children
howev
pure
viral
pneumonia
occur
associ
varicella
adult
tendenc
viru
affect
lung
rel
commonli
varicella
fifteen
twenti
percent
adult
varicella
may
xray
evid
pneumonia
requir
hospit
frequent
adult
varicella
pneumonia
complic
bacteri
suprainfect
howev
occur
particularli
patient
requir
intub
viru
reach
lung
passag
respiratori
tract
hematogen
seed
rash
occur
time
pneumonia
initi
pneumon
process
appear
nodular
infiltr
mm
diamet
associ
interstiti
inflammatori
infiltr
lesion
dens
toward
hilum
counterpart
lung
pox
occur
skin
figur
peribronchi
inflammatori
infiltr
hilar
adenopathi
pleural
effus
may
occur
reticulonodular
interstiti
infiltr
progress
widespread
alveolar
damag
diffus
pulmonari
parenchym
infiltr
patholog
pneumonia
resembl
influenza
pneumonia
except
area
coagul
necrosi
seen
although
necrot
area
gener
clear
cours
clinic
diseas
becom
calcifi
radiograph
show
pictur
miliari
calcif
shown
area
coagul
necrosi
becom
surround
inflammatori
infiltr
resembl
granuloma
fibrou
tissu
envelop
necrot
granulomat
process
lesion
eventu
calcifi
anoth
process
occur
varicella
pneumonia
destruct
epithelium
trachea
bronchi
case
ill
protract
develop
thick
fibrinopurul
crust
may
occur
lower
pharynx
larynx
upper
trachea
thick
crust
caus
respiratori
embarrass
pose
problem
intub
dissemin
herp
zoster
caus
process
lung
normal
adult
recov
varicella
pneumonia
without
difficulti
substanti
respiratori
morbid
mor
figur
varicella
pneumonia
chest
radiograph
lett
case
report
describ
protocol
closeup
film
right
anoth
pallent
show
peribronchi
infiltr
multipl
round
opac
right
lung
field
taliti
immunosuppress
patient
women
third
trimest
ofpregn
clinic
patient
varicellazost
viru
pneumonia
present
rash
follow
cough
dyspnea
sputum
initi
white
modest
amount
becom
hemorrhag
process
complic
develop
chest
pain
pleural
effus
often
blood
ting
relat
presenc
pox
pleural
surfac
extrapulmon
manifest
varicella
occur
consist
characterist
skin
rash
otiti
media
bacteri
suprainfect
myopericard
hepat
dysfunct
enceph
rey
syndrom
complic
cours
ofvaricella
associ
glomerulonephr
varicella
viru
occasion
induc
frank
arthriti
care
patient
varicellazost
viru
pneumonia
import
realiz
extern
appear
patient
appar
wellb
may
disguis
underli
hypoxemia
effort
made
diagnos
correct
hypoxemia
patient
may
becom
confus
perform
inappropri
activ
becom
hypoxem
ventil
support
may
becom
necessari
death
varicella
pneumonia
occur
respiratori
insuffici
develop
tension
pneumothorac
bacteri
suprainfect
progress
pulmonari
fibrosi
two
antivir
compound
adenin
arabinosid
araa
acyclovir
acv
proven
effici
treatment
signific
complic
varicellazost
viru
infect
adenin
arabinosid
inhibit
viral
dna
polymeras
given
dosag
mglkg
period
least
day
dosag
could
increas
mglkg
american
journal
medic
scienc
major
experi
varicellazost
viru
infect
mglkgday
drug
sparingli
solubl
ml
vehicl
requir
milligram
drug
administ
patient
dose
mglkg
bone
marrow
suppress
usual
occur
dose
decreas
set
hepat
renal
dysfunct
central
nervou
system
disturb
consist
insomnia
hallucin
tremul
may
occur
central
nervou
system
manifest
usual
fade
stop
drug
rare
lead
death
persist
protract
period
drug
discontinu
acyclovir
also
use
treat
varicellazost
viru
infect
inhibit
viral
dna
polymeras
also
act
chain
termin
dosag
mgm
everi
hour
least
day
signific
problem
administr
acyclovir
set
product
obstruct
nephropathi
due
salt
drug
collect
tubul
ofth
kidney
usual
easili
manag
administr
fluid
bolu
diuret
mannitol
comparison
two
drug
complic
varicellazost
viru
infect
made
one
group
found
acyclovir
efficaci
studi
determin
araa
equal
effect
administr
araa
requir
increas
volum
fluid
associ
central
nervou
system
side
effect
author
consid
acyclovir
drug
choic
treatment
complic
infect
due
varicellazost
viru
oral
acyclovir
absorb
poorli
gastrointestin
tract
efficaci
uncompl
herp
zoster
appar
mg
given
time
day
least
period
experi
oral
acv
treat
varicella
pneumonia
futur
mode
therapi
may
includ
combin
araa
acv
administ
one
drug
interferon
prepar
alphainterferon
also
shown
effect
therapi
complic
varicellazost
viru
infect
use
superced
acv
araa
case
report
varicella
pneumonia
man
expos
two
children
chicken
pox
two
day
admiss
develop
rash
dyspnea
physic
examin
typic
varicella
rash
present
sever
respiratori
distress
rale
present
diffus
lung
field
chest
radiograph
reveal
bilater
extens
alveolar
infiltr
arteri
blood
gase
show
ph
intub
begun
posit
endexpiratori
pressur
peep
start
intraven
acyclovir
everi
hour
improv
abl
extub
day
comment
sever
varicella
pneumonia
respond
intraven
acyclovir
oxygen
maintain
peep
high
herp
simplex
viru
caus
necrot
bronchopneumonia
neonat
infect
also
caus
pneumonia
sever
immunosuppress
adult
patient
largest
seri
patient
herp
simplex
viru
pneumonia
report
seattl
bonemarrow
transplant
recipi
consist
patient
either
focal
pneumonia
patient
diffus
interstiti
pneumonia
eight
patient
focal
pneumonia
found
associ
herpet
esophag
tracheiti
probabl
result
contigu
spread
herp
viru
lung
parenchyma
diffus
interstiti
pneumonia
probabl
result
hematogen
dissemin
viru
lung
patholog
process
one
necrot
bronchopneumonia
widen
interstiti
space
lung
associ
diffus
alveolar
injuri
highli
immunosuppress
patient
bacteri
fungal
suprainfect
occur
difficult
sort
process
respons
proport
lung
damag
acyclovir
shown
effect
treatment
complic
herp
simplex
viru
infect
immunosuppress
patient
dose
usual
patient
mgm
everi
hour
least
day
process
ascertain
rapidli
progress
herpet
pneumonia
dose
could
increas
mglkg
everi
hour
therapeut
respons
obtain
develop
potent
antivir
chemotherapi
need
consid
diagnos
herpet
pneumonia
specif
diagnosi
accomplish
readili
lung
biopsi
although
involv
lung
infecti
mononucleosi
due
epsteinbarr
viru
must
consid
rare
occurr
recent
studi
case
report
demonstr
probabl
happen
care
attent
given
possibl
coexist
mycoplasma
viral
infect
particularli
sinc
former
treat
radiograph
abnorm
may
consist
hilar
adenopathi
strandlik
parenchym
infiltr
diffus
bilater
pneumonia
pictur
consist
primari
atyp
pneumonia
although
epsteinbarr
viru
suscept
acyclovir
report
treat
lung
involv
drug
cytomegaloviru
cmv
rare
caus
pneumonia
normal
adult
part
cmv
mononucleosi
syndrom
howev
common
cmv
induc
pneumonia
normal
host
epsteinbarr
viru
patient
communityacquir
pneumonia
serolog
evid
cmv
infect
ten
patient
immunosuppress
five
ten
cmv
pathogen
remain
five
patient
one
coexist
infect
c
trachomati
two
pneumonia
one
epsteinbarr
viru
one
bacteria
three
aerob
anaerob
cytomegaloviru
commonli
caus
pneumonia
immunosuppress
patient
occur
particularli
renal
heart
liver
bonemarrow
transplant
recipi
becom
increas
problem
patient
aid
transplant
recipi
experienc
primari
cmv
infect
viru
probabl
reach
lung
parenchyma
hematogen
rout
first
find
reticulonodular
infiltr
presenc
mm
opac
figur
patholog
focal
area
usual
consist
necrot
tissu
hemorrhag
alveolar
damag
edema
mononuclear
infiltr
typic
cytomegal
cell
process
extend
lead
diffus
interstiti
alveolar
infiltr
attempt
made
separ
forego
process
insidi
develop
interstiti
pneumonia
occur
commonli
reactiv
infect
better
prognosi
bone
marrow
transplant
recipi
diffus
interstiti
pneumon
due
cmv
much
common
patient
receiv
allogen
transplant
casefat
rate
approxim
renal
transplant
recipi
pneumon
process
focal
except
sever
small
pleural
effus
occur
occasion
renal
transplant
recipi
howev
cmv
pneumonia
progress
rapidli
lead
death
part
wide
dissemin
infecti
process
cardiac
transplant
recipi
varieti
pulmonari
opportunist
suprainfect
well
document
occur
cours
cmv
pneumonia
typic
microorgan
caus
suprainfect
includ
p
carinii
nocardia
speci
patient
aid
may
coexist
infect
pneumocysti
cure
pneumocysti
effect
drug
leav
cmv
major
pulmonari
pathogen
patient
aid
rapid
develop
cmv
pneumonia
occur
lead
death
patient
extrapulmon
manifest
cmv
renal
transplant
recipi
includ
fever
malais
hepat
dysfunct
splenomegali
leukopenia
increas
serum
creatinin
extens
cmv
dissemin
heavili
immunosuppress
patient
includ
aid
extrapulmon
manifest
includ
gastrointestin
ulcer
bleed
perfor
hepat
dysfunct
adren
cortic
involv
central
nervou
sytem
dysfunct
cytomegaloviru
thought
immunosuppress
viral
agent
infect
microorgan
may
lead
immunosuppress
consequ
bacteri
fungal
parasit
suprainfect
clinic
patient
cmv
pneumonia
complain
dyspnea
nonproduct
cough
associ
pleurisi
process
transient
extend
respiratori
insuffici
necessit
ventilatori
support
therapi
fulli
develop
cmv
pneumonia
shown
effect
includ
use
adenin
arabinosid
acyclovir
ganciclovir
dhpg
combin
interferon
ganciclovir
success
achiev
antivir
effect
lung
yet
improv
outcom
american
journal
medic
scienc
bone
marrow
transplant
recipi
cmv
pneumonia
occasion
renal
transplant
recipi
potenti
good
immun
respons
viru
cmv
ill
includ
local
pneumonia
might
benefit
judici
use
ganciclovir
attempt
prevent
cmv
pneumonia
includ
donor
select
avoid
white
blood
cell
transfus
prophylact
administr
alphainterferon
yglobulin
prepar
given
first
day
transplant
alphainterferon
prevent
cmv
viremia
renal
transplant
recipi
yglobulin
protect
partial
cmv
pneumonia
white
blood
cell
transfus
given
studi
progress
tri
make
latter
effect
consist
consist
determin
whether
total
antibodi
content
necessari
compon
whether
effect
necessit
presenc
oflarg
quantiti
neutral
antibodi
prioriti
basi
live
attenu
cmv
vaccin
develop
curtail
immedi
futur
homosexu
man
present
hospit
fever
cough
erythemat
rash
follow
clinic
aidsrel
complex
lymphadenopathi
thrush
lymphopenia
anergi
diarrhea
posit
antibodi
test
human
immunodefici
viru
time
acut
termin
ill
temperatur
c
diffus
erythemat
prurit
rash
trunk
upper
leg
admiss
chest
radiograph
interpret
normal
second
hospit
day
patient
becam
deliri
worsen
cough
develop
sever
dyspnea
arteri
blood
gase
room
air
reveal
ph
pco
po
chest
radiograph
reveal
bilater
diffus
reticulonodular
infiltr
start
sulfatrimethoprim
respiratori
arrest
die
postmortem
examin
reveal
cmv
pneumonia
without
evid
ofpneumocysti
lung
viral
cultur
rapidli
grew
cmv
cytopath
effect
present
second
day
comment
explos
ill
patient
arc
reveal
cmv
autopsi
viral
cultur
lung
